BidaskClub Lowers Utah Medical Products (NASDAQ:UTMD) to Strong Sell

BidaskClub lowered shares of Utah Medical Products (NASDAQ:UTMD) from a sell rating to a strong sell rating in a report released on Tuesday, BidAskClub reports.

Separately, ValuEngine raised Utah Medical Products from a hold rating to a buy rating in a research report on Tuesday, February 4th.

UTMD opened at $93.20 on Tuesday. Utah Medical Products has a 1-year low of $76.60 and a 1-year high of $112.26. The stock has a market capitalization of $346.50 million, a price-to-earnings ratio of 23.65 and a beta of 0.78. The business has a 50 day moving average of $101.00 and a 200-day moving average of $99.21.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, January 30th. The medical instruments supplier reported $1.01 EPS for the quarter. The firm had revenue of $11.83 million during the quarter. Utah Medical Products had a return on equity of 15.10% and a net margin of 31.40%.

In related news, CEO Kevin L. Cornwell sold 800 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $107.67, for a total value of $86,136.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin L. Cornwell sold 584 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $107.05, for a total value of $62,517.20. The disclosure for this sale can be found here. 7.30% of the stock is owned by company insiders.

Hedge funds have recently modified their holdings of the stock. Bank of Montreal Can raised its stake in Utah Medical Products by 44.6% during the fourth quarter. Bank of Montreal Can now owns 441 shares of the medical instruments supplier’s stock worth $48,000 after acquiring an additional 136 shares in the last quarter. Bessemer Group Inc. raised its stake in Utah Medical Products by 1.6% during the fourth quarter. Bessemer Group Inc. now owns 12,600 shares of the medical instruments supplier’s stock worth $1,360,000 after acquiring an additional 200 shares in the last quarter. Martingale Asset Management L P raised its stake in Utah Medical Products by 0.9% during the fourth quarter. Martingale Asset Management L P now owns 23,302 shares of the medical instruments supplier’s stock worth $2,516,000 after acquiring an additional 200 shares in the last quarter. Citigroup Inc. raised its stake in Utah Medical Products by 49.2% during the fourth quarter. Citigroup Inc. now owns 707 shares of the medical instruments supplier’s stock worth $76,000 after acquiring an additional 233 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in Utah Medical Products by 23.7% during the fourth quarter. Victory Capital Management Inc. now owns 1,684 shares of the medical instruments supplier’s stock worth $182,000 after acquiring an additional 323 shares in the last quarter. 76.19% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Read More: What does a market perform rating mean?

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.